AAPP Scientific Poster Session Abstracts

A Breath of Fresh Air: Treatment of Intramuscular Naltrexone-Induced Eosinophilic Pneumonia Substance-Use Disorders VA Adverse Drug Reaction

A Combination of Olanzapine and Samidorphan in Adults With Schizophrenia and Bipolar I Disorder: Overview of Clinical Data Antipsychotics Neurology Schizophrenia Bipolar Disorder Olanzapine Samidorphan

A Comparison of Erenumab versus Botulinum among Veterans with Chronic Migraines in the setting of COVID-19 Adherence Neurology VA Migraine

A Comparison of Prazosin and Topiramate for the Treatment of Alcohol Use Disorder in Veterans with PTSD Post-Traumatic Stress Disorder/ PTSD Substance-Use Disorders VA Alcohol Use Disorder Prazosin Topiramate

A Comparison of the Pharmacokinetics, Efficacy, and Tolerability of Long-Acting Injectable Risperidone Formulations Adherence Antipsychotics Long-Acting Injectable Schizophrenia

A Pharmacist-Developed Algorithm to Improve UTI Antibiotic Appropriateness at an Inpatient Psychiatric Hospital Adherence Education/Stigma Transitions Of Care Antibiotics Urinary Tract Infection

A Retrospective Study Evaluating the Role of Atomoxetine in Improving Outcomes in Patients with Attention Hyperactivity Disorder and Comorbid Substance Use Disorder Long-Acting Injectable Stimulants Substance-Use Disorders VA

A Retrospective Study of Pharmacist versus Psychiatrist-Led Medication Management in an Outpatient Setting Adherence VA

A Survey of Health Care Professionals: Is a New Nomenclature Needed for Atypical Antipsychotics? Antidepressants Antipsychotics Mood Stabilizers Nomenclature Atypical Antipsychotic

Access to Medications for Opioid Use Disorder Within Integrated Healthcare Systems: Barriers and Potential Solutions Opioids Substance-Use Disorders Health Services Research Treatment Access

Addition of a Clinical Pharmacy Specialist to an Inpatient Addiction Triage Team and Related Medication Outcomes Substance-Use Disorders VA

Adjusting Long Acting Injectable Antipsychotic Regimens to Reduce Patient and Clinician Risk During the COVID-19 Pandemic Adherence Antipsychotics Long-Acting Injectable VA

Adverse Effects of Combination Antipsychotic Therapy in a Forensic Patient Population Antipsychotics Adverse Drug Reaction Forensic

Alcohol Use Disorder Pharmacotherapy Education for Veterans Hospitalized for Acute Withdrawal Management Substance-Use Disorders Transitions Of Care Alcohol Use Disorder 30-Day Readmissions Pharmacotherapy

Alcohol Use Education and Alcohol Use Disorder Pharmacotherapy Management in Primary Care Substance-Use Disorders VA

Analysis of Patient-Reported Satisfaction with Long-Acting Injectables for Opioid and Alcohol Use Disorder in a Central Texas Outpatient Clinic Long-Acting Injectable Opioids Substance-Use Disorders Alcohol Use Disorder Buprenorphine Naltrexone

Analysis of Pharmacy Student's and Professional's Perception of Efficacy and Risk of Psychotropic Medications Through Estimated Number-needed-to-treat and Number-needed-to harm Antidepressants Antipsychotics Anxiolytics Child And Adolescent Psychiatry Education/Stigma Geriatrics Neurology Stimulants Suicide Mood Stabilizers

Analysis Of Student Pharmacists’ Self-Reported Intention To Provide Harm Reduction Resources After Brief Education And A Simulated Patient Encounter Education/Stigma Opioids Substance-Use Disorders Harm Reduction Overdose Response

Analysis of Trends in Anxiety in Professional Pharmacy Students; A Follow-up Study: Evaluating the relationship between Anxiety and caffeine intake, hours of sleep, and perceived loneliness in Professional Pharmacy Students. Education/Stigma Anxiety Caffeine Loneliness Sleep

Analyzing the Effect of Art Therapy Interventions and Wellness Programs on Graduate Pharmacy Students’ Mental Health Education/Stigma Student Mental Health Pharmacy Education Resiliency

Anticholinergic use and antipsychotic initiation in dementia: an evaluation of prescribing at a Veterans Affairs Medical Center Antipsychotics Geriatrics VA Dementia Anticholinergic

Antipsychotic Use at a Skilled Nursing Facility Antipsychotics Geriatrics

Anxiety in Professional Pharmacy Students: A Literature Review on Anxiety and Effective Coping Mechanisms Education/Stigma Anxiety Stress Coping Mechanism

Assessing Adherence and Persistence to Long-Acting Injectable Antipsychotics Initiated in the Inpatient Setting Adherence Antipsychotics Long-Acting Injectable Transitions Of Care

Assessing Patient-Reported Outcomes and Pharmacist Interventions in Neurology Specialty Disease States within an Integrated Care Center Adherence Neurology Patient-Reported Outcomes

Assessing the characteristics of Veterans over 65 who are prescribed benzodiazepines: comparing Veterans in mental health clinics and primary care clinics Anxiolytics Geriatrics VA Benzodiazepine Discontinuation Taper

Assessing the Clinical Outcomes surrounding Deep Brain Stimulation in the Treatment of Refractory Obsessive-Compulsive Disorder: A Case-Cohort Study Adherence Antidepressants Anxiolytics Geriatrics Suicide Obsessive-Compulsive Disorder Deep Brain Stimulation

Assessing the Need for Gender Diverse Education Amongst Practicing Community Pharmacists Education/Stigma Gender Trans-Inclusive

Assessing the prevalence of drugs listed in American Geriatric Society Beers Criteria for Potentially Inappropriate Medication Use in non-critically ill hospitalized geriatric patients Geriatrics Beers Criteria

Assessing Use of Population Management Tools to Promote Safety for Long-Acting Injectable Psychotropic Medications Adherence Antipsychotics Long-Acting Injectable Substance-Use Disorders Transitions Of Care VA Population Health Management Medication Errors

Assessment of a Comprehensive Naloxone Education Program’s Impact on Community Member Knowledge and Attitudes on a College Campus Education/Stigma Opioids Substance-Use Disorders

Assessment of Anticholinergic Polypharmacy in the Elderly at a Community Psychiatric Hospital Antidepressants Antipsychotics Anxiolytics Education/Stigma Geriatrics Transitions Of Care Anticholinergic Cognition

Assessment of Hepatitis C Treatment Sustained Virologic Response in Veterans with Substance Use and Prevalence of Reinfection Substance-Use Disorders Transitions Of Care VA Hepatitis Monitoring

Assessment of Monitoring for Orthostatic Hypotension in Adults 60 Years and Older Being Treated with Select Antipsychotics at an Academic Medical Center. Antipsychotics Geriatrics Monitoring Orthostatic Hypotension

Assessment of Opioid Withdrawal with The Clinical Opiate Withdrawal Scale (COWS) Treatment Protocol at A Community Psychiatric Hospital Opioids Substance-Use Disorders

Association Between Therapeutic Outcomes of Antidepressants (SSRI) and Pharmacogenetics in Patients with Neurodevelopmental Disorders Antidepressants Pharmacogenomics Neurodevelopmental Disorder

Attitudes and Perceptions About the Use of Long-Acting Injectable Antipsychotics Among Behavioral Health Providers Antipsychotics Education/Stigma Long-Acting Injectable

Benzodiazepine Prescribing Patterns at an Outpatient Family Medicine Clinic Anxiolytics Geriatrics

Brand-Based Differences in Neutropenia Risk: A Case Report of Aripiprazole-induced Neutropenia Neutropenia Excipients Atypical Antipsychotic Generic

Buprenorphine Prescribing Practices in United States Emergency Departments Education/Stigma Opioids Substance-Use Disorders

Burning Mouth Syndrome Responsive to Gabapentin: A Case Report Antidepressants Antipsychotics Substance-Use Disorders Depression Burning Mouth Syndrome Anticonvulsants

Cardiometabolic Safety of Lumateperone (ITI-007): Post Hoc Analyses of Short-Term Randomized Trials and an Open-Label Long-Term Study in Schizophrenia Antipsychotics Schizophrenia Metabolic Syndrome Lumateperone

Cataloguing the Impact of Psychiatric Pharmacist through Literature Patient-Level Outcomes Neurologic Pharmacist Interprofessional Team Medication Management

Characterization of Commercial Cannabidiol Oil Products and the In-vitro Biomodulation of Citalopram and Escitalopram Antidepressants Anxiolytics Cannabidiol Escitalopram Citalopram

Clinical Pharmacist Outreach to Improve Continuation Phase Depression Management in Adults within a Safety Net Institution Adherence Antidepressants Safety

Clinical Utility of Pharmacogenomic Testing in a Veteran Mental Health Population Antidepressants Antipsychotics Pharmacogenomics VA Veteran

Clinician Perception of Initiating Buprenorphine for Patients with Opioid Use Disorder Following Virtual Simulation Experiences Opioids Substance-Use Disorders VA Simulation Buprenorphine

Collaborative Advocacy Between Student CPNP and APhA-ASP Chapters for MFHA Inclusion Across All PharmD Curricula Education/Stigma Substance-Use Disorders Advocacy Mental Health First Aid

Comparative Bioavailability of Amphetamine Extended-Release Oral Suspension and Extended-Release Mixed Amphetamine Salts Stimulants ADHD Pharmacokinetics

Comparison of Antipsychotic Prescribing Practices Following Failure of Antipsychotic Monotherapy in the Acute Care Setting Antipsychotics VA Schizophrenia

Comparison of Clozapine Dosing and Tolerability in Patients with and without Concurrent Divalproex Sodium Antipsychotics Mood Stabilizers

Comparison of Healthcare Utilization Rates Among Patients with a Stimulant Use Disorder or Opioid Use Disorder in a Veteran Population Opioids Stimulants Substance-Use Disorders VA

Consumer Perception, Knowledge, and Uses of Cannabidiol Education/Stigma Substance-Use Disorders Cannabidiol

Continuation and Improvement of a Personality Disorder Treatment Protocol at a Veterans Affairs Medical Center Education/Stigma VA Personality Disorder

Deprescribing in Older Adults during Inpatient Psychiatric Hospitalization: Impact of Pharmacist Intervention and Interprofessional Collaboration Geriatrics Suicide Deprescribing Polypharmacy

Description of Psychiatric Pharmacist-led Interventions Post Hospital Discharge within an Integrated Health System Transitions Of Care

Developing and Establishing Psychiatric and Behavioral Health Ambulatory Clinical Pharmacy Services Within a Large Heath System Transitions Of Care Ambulatory Care Collaborative Practice

Development and Implementation of a Long-Acting Injectable Procedure at a Veterans Affairs Medical Center Antipsychotics Long-Acting Injectable VA

Development, Implementation, and Evaluation of a Clinical Tool Kit for the Care of Patients Receiving Clozapine in Acute Psychiatry Antipsychotics Clozapine

Dialectical Behavior Therapy’s Impact on Psycho-Polypharmacy Minimization in Veterans with Borderline Personality Disorder Antidepressants Antipsychotics Anxiolytics Post-Traumatic Stress Disorder/ PTSD VA Mood Stabilizers Polypharmacy Veteran Personality Disorder

Do Buprenorphine Doses & Ratios Matter in Medication Assisted Treatment (MAT) Retention? Adherence Opioids Substance-Use Disorders Medication Assisted Treatment Buprenorphine

Effect of A Subcutaneous Weekly and Monthly Buprenorphine (CAM2038) Extended-Release Dose on Opioid Use Disorder (OUD) Treatment Outcomes Opioids Substance-Use Disorders Buprenorphine Opioid Use Disorder

Effect Of Pharmacogenetics-Based Decision Support Strategies In Improving Depression Outcomes: A Systematic Review Antidepressants Pharmacogenomics Depression Pharmacogenetics

Effect of Phenobarbital on Benzodiazepine Usage for Alcohol Withdrawal Substance-Use Disorders Alcohol Withdrawal

Effect of Prescriber Education on Off-Label Quetiapine Use in Veterans diagnosed with PTSD Antipsychotics Education/Stigma Post-Traumatic Stress Disorder/ PTSD VA

Effectivenss Analysis of Olanzapine Compared to Other Antipsychotics for the Treatment of First-Episode Psychosis Antipsychotics First-Episode Psychosis Schizophrenia

Effects of Different Cannabidiol (CBD) Oils on the Anti-Seizure Medication Phenytoin Anticonvulsants Cannabidiol In Vitro Metabolism

Effects of Early Engagement with Opioid Treatment Programs on Successful Transitions of Care Opioids Transitions Of Care

Efficacy and tolerability of KarXT (xanomeline/trospium) in a Phase 2 placebo-controlled trial in schizophrenia Antipsychotics Muscarinic

Efficacy of Esketamine in Conjunction with Adjunctive Atypical Antipsychotics in Patients with Major Depressive Disorder and Active Suicidal Ideation with Intent Antidepressants Suicide Esketamine Major Depression Atypical Antipsychotic Safety

Efficacy of Lumateperone (ITI-007) in Depression Symptoms Associated With Schizophrenia Antipsychotics Schizophrenia Lumateperone

Efficacy of Medication Means Restriction in Veterans with High-Risk Suicide Flags Suicide VA

Eliminating Medications Through Patient Ownership of End Results (EMPOWER): A Reduction of Potentially Inappropriate Benzodiazepine Use In High-Risk Patients. Anxiolytics Geriatrics Opioids Post-Traumatic Stress Disorder/ PTSD Substance-Use Disorders VA

Evaluating Pharmacotherapy Augmentation and Progression for the Treatment of Severe Obsessive-Compulsive Disorder Adherence Antidepressants Antipsychotics Anxiolytics Mood Stabilizers Obsessive-Compulsive Disorder

Evaluating Psychotropic Medication Use in Pregnant Veterans with a Mental Illness Adherence Antidepressants Antipsychotics Anxiolytics VA Mood Stabilizers Pregnancy Psychotropics Veteran

Evaluating The Efficacy and Safety of Switching from Onabotulinum Toxin Type A to Erenumab-aooe during COVID-19 Neurology VA Migraine Headache

Evaluating the Impact of a Prior Authorization Drug Request (PADR) Consult on Appropriate Initiation of Benzodiazepines Amongst Primary Care Providers Anxiolytics Substance-Use Disorders VA

Evaluating the Impact of a Substance Use Disorder Clinical Pharmacy Specialist on Access to Care in a Mental Health Outpatient Treatment Program Opioids Substance-Use Disorders Alcohol Use Disorder Opioid Use Disorder Clinical Pharmacy Specialist Medication Assisted Treatment

Evaluating the Impact of Clinical Pharmacy Specialist in the Treatment of Alcohol Use Disorder Substance-Use Disorders VA Alcohol Use Disorder

Evaluating the Impact of Pharmacogenetic Testing on Medication Changes in Veterans with Mental Health Conditions Pharmacogenomics VA

Evaluating the Safety and Efficacy of Reducing Clozapine Blood Test Monitoring in Veterans Stable on Clozapine Therapy Antipsychotics VA

Evaluation of Atypical Long-Acting Injectable Antipsychotics for Substance-Induced Psychosis in a Veteran Population Antipsychotics Long-Acting Injectable VA Substance-Induced Psychosis

Evaluation of Buprenorphine for Medication Opioid Use Disorder in the Emergency Department Opioids Substance-Use Disorders

Evaluation of Clinical Pharmacist Management Trends for Depression Antidepressants Primary Care

Evaluation of Clozapine-Induced Constipation and COVID-19 Antipsychotics COVID-19 Clozapine Constipation Laxatives

Evaluation of Commercially Available Cannabidiol Oils on the Metabolism of Commonly Prescribed Opioid Medications Opioids Cannabidiol In Vitro Metabolism

Evaluation of Electrocardiogram (ECG) Monitoring in High Risk Patients Taking Known QTc Prolonging Drugs Antidepressants Antipsychotics Anxiolytics QTc Prolongation Drug Monitoring

Evaluation of Initial Prescribing of Benztropine or Diphenhydramine for Extrapyramidal Symptoms (EPS) in patients on Antipsychotic Therapy. Antipsychotics VA Anticholinergic Extrapyramidal Symptoms Pseudoparkinsonism Tardive Dyskinesia Akathisia

Evaluation of Once-Daily Opicapone 50 mg in Patients with Parkinson’s Disease and Motor Fluctuations: Pooled Efficacy and Safety Analyses of Two Randomized, Double-Blind, Placebo-Controlled Studies (BIPARK-1 and BIPARK-2) Neurology Parkinson's Disease Opicapone

Evaluation Of Oral Antipsychotics Adherence and Time To Decompensation Among Veterans With Schizophrenia Adherence Antipsychotics Veteran

Evaluation of Outcomes in the Emergency Department Following Implementation of a Rating Scale and Order Set for Acute Agitation Antipsychotics Anxiolytics Acute Agitation Emergency Department

Evaluation of Patients with a Diagnosis of Opiate Use Disorder Without Medication Assisted Therapy Antipsychotics Opioids Substance-Use Disorders VA Opioid Use Disorder

Evaluation of Pharmacogenomic Testing Antidepressants Pharmacogenomics

Evaluation of Pharmacogenomic Testing Utility on Restraint Use and Polypharmacy in a Forensic Psychiatric Hospital Antipsychotics Pharmacogenomics Polypharmacy Restraint Forensic

Evaluation of Safety in Veterans Maintained on Clozapine with Nonstandard Absolute Neutrophil Count (ANC) Monitoring during the Corona Virus (COVID-19) Pandemic Antipsychotics VA Clozapine Antipsychotic Monitoring COVID-19

Evaluation of The Appropriateness of Benzodiazepine (BZD) Prescribing. Opioids Post-Traumatic Stress Disorder/ PTSD Substance-Use Disorders VA Benzodiazepine

Evaluation of the Relationship Between Opioids and Suicidality Among Veterans Opioids Suicide

Evaluation of the Safety of Intranasal Esketamine in VA using a Real Time (Prospective) MUE. Antidepressants VA Esketamine Adverse Drug Reaction Safety

Evaluation of Treatment Outcomes of Conversion to Aripiprazole Lauroxil from Aripiprazole Monohydrate Antipsychotics Long-Acting Injectable

Evaluation of Z-Drug Use in Adult Patients at a Federally Qualified Health Center Geriatrics Sleep Disorder Nonbenzodiazepine Receptor Agonists

Expanding Access to Clozapine in a Veterans Affairs Community Based Outpatient Clinic (VA CBOC) Setting Antipsychotics VA

Expanding Access to Naloxone with Student Pharmacists and Academic Detailing Education/Stigma Opioids Substance-Use Disorders Naloxone

Exploring Community Pharmacists’ Attitudes of Deregulating and Dispensing Methadone in Community Pharmacies Opioids Substance-Use Disorders

Factors Associated with Treatment Response in Lamotrigine Prophylaxis in Patients with Bipolar Disorder VA Mood Stabilizers Bipolar Disorder Lamotrigine

Free and Total Serum Valproic Acid Concentrations: Association with Clinical Response and Toxicities Mood Stabilizers Pharmacokinetics

Health and Wellness in Pharmacy Students During the COVID-19 Pandemic Education/Stigma Wellness COVID-19

Healthcare Resource Utilization and Costs in Patients with Bipolar Disorder Treated with Lurasidone or Cariprazine: A Retrospective Analysis of Insurance Claims Data Antipsychotics Long-Acting Injectable Healthcare Resource Utilization Costs Bipolar Disorder

Impact of a Neuropsychiatric Therapeutics Course and a Subsequent Case-Based Course on Mental Health Stigma among Pharmacy Students Education/Stigma Survey

Impact of a Pharmacist Driven Diabetes Monitoring Service in an Acute Psychiatric County Facility Antipsychotics Diabetes Metabolic Syndrome

Impact of a Pharmacist-led Telemental Health Transitions of Care Clinic on Psychotropic Medication Adherence Adherence Antidepressants Antipsychotics VA Mood Stabilizers

Impact of a Resident-driven Wellness Committee on Resident-perceived Wellness, Burnout, and Resilience Education/Stigma Burnout Wellness Resiliency

Impact of a Virtual Mental Health First Aid Elective Course on Stigma in Students of a Three-Year Doctor of Pharmacy Program Education/Stigma Suicide Academia Mental Health First Aid

Impact of Clozapine Monitoring Overrides Due to COVID-19 VA Clozapine REMS

Impact of COVID-19 Pandemic on Health Care Utilization and Overall Stability of Patients with Schizophrenia/Schizoaffective Disorder Adherence Antipsychotics Transitions Of Care VA COVID-19

Impact of CYP2C19 Metabolizing Phenotypes on the Treatment of Anxiety and Depression with Sertraline, Escitalopram, or Citalopram Antidepressants Anxiolytics Pharmacogenomics Precision Medicine Pharmacogenetics

Impact of Implementation of Stimulant Medication Order Menu on Psychostimulant Prescribing Stimulants Substance-Use Disorders

Impact of Long-Acting Injectable Antipsychotic Administration During Psychiatric Admission versus Deferral to Outpatient Care Adherence Antipsychotics Long-Acting Injectable Transitions Of Care

Impact of Non-traditional vs Traditional Initiation Dosing Schedule of Paliperidone Palmitate on Readmission and Safety Adherence Antipsychotics Long-Acting Injectable Paliperidone Palmitate

Impact of Pharmacist Interventions Related to the Safety of Long-term Corticosteroid Use in Myasthenia Gravis Patients Neurology Pharmacist Intervention Ambulatory Care Corticosteroids

Impact of SARS-CoV-2 on Mental Health Education and the Adaptation to a Virtual Setting Education/Stigma COVID-19

Implementation of a long-acting injectable antipsychotic clinic at a Veterans Affairs Medical Center Adherence Antipsychotics Long-Acting Injectable VA

Implementation of a Medication-Assisted Treatment (MAT) Program within an Inpatient Psychiatric Hospital Adherence Substance-Use Disorders Transitions Of Care

Implementation of a Pharmacist as the Sole Prescriber in a Primary Care Mental Health Integration Clinic at a Federal Health Care Center VA Primary Care Mental Health Integration Clinic

Implementation of a Pharmacist-Led Intervention for the Treatment of Alcohol Use Disorder Substance-Use Disorders VA

Implementation of a Psychiatric Pharmacist in the Emergency Department Substance-Use Disorders VA

Implementation of Depression Screenings at a University-Affiliated Community Pharmacy with COVID-19 Procedure Education/Stigma Suicide Depression

Implementation of Pharmacy Services in Achieving Optimized Compliance to IPFQR Tobacco Use Measures Smoking Cessation

Implementation of Therapeutic Drug Monitoring in Patients on Dual Second Generation Antipsychotics in a Correctional Setting Antipsychotics Therapeutic Drug Monitoring

Improvements in the Inpatient to Outpatient Transitions of Care Process for Patients Prescribed Clozapine Antipsychotics Education/Stigma Transitions Of Care Collaborative Drug Therapy Management

Improving Acute Alcohol Withdrawal Syndrome Management in a Community Based Hospital Anxiolytics Education/Stigma Substance-Use Disorders

Improving Hospital-wide Prescribing Practices through Pharmacist-initiated Physician Peer Comparison Letters Antipsychotics Polypharmacy Prescribing Practices

Influence of Chronobiotic-dosed Melatonin on Key Outcomes During Major Cognitive Disorder-related Geriatric Admissions Geriatrics

Initiation of a Benzodiazepine Tapering Clinic for Veterans with Opioid and Alcohol Use Disorders Opioids Substance-Use Disorders VA Benzodiazepine Deprescribing

Initiation of Antipsychotic Treatment for Amphetamine Induced Psychosis and its Impact on Length of Stay Antipsychotics Substance-Use Disorders

Institution of an Acute Agitation Order Set at a Veterans Affairs Medical Center Antipsychotics Anxiolytics VA Acute Agitation

Integration of Mental Health Clinical Pharmacy Specialists to Limit Access to Lethal Means in Veterans Identified as High Risk for Suicide Suicide Transitions Of Care VA

Long- and Short-Term Disability and Workers' Compensation Trends for Employees with Mental Disorders in the United States Neurology Disability Absence

Long- and Short-Term Disability and Workers' Compensation Trends for Employees with Substance Abuse Mental Disorders in the United States Substance-Use Disorders Disability Absence

Long-Term Antipsychotic Efficacy of Olanzapine and Samidorphan Combination in Patients With Schizophrenia: Pooled Analyses From Phase 3 Studies Antipsychotics Schizophrenia Bipolar Disorder Olanzapine Samidorphan Long-Term Care

Long-Term Safety of Olanzapine and Samidorphan Combination in Patients With Schizophrenia: Pooled Analyses From Phase 2 and 3 Studies Antipsychotics Schizophrenia Bipolar Disorder Olanzapine Samidorphan Safety

Long-Term Weight and Metabolic Effects of Olanzapine and Samidorphan Combination in Patients With Schizophrenia: Pooled Analyses From Phase 3 Studies Antipsychotics Schizophrenia Bipolar Disorder Olanzapine Samidorphan

Longitudinal Assessment of Pharmacy Student Attitudes Towards Mental Illness Adherence Education/Stigma

Lumateperone (ITI-007) in the Treatment of Bipolar Depression: Results from a Randomized Clinical Trial Antipsychotics Bipolar Disorder Lumateperone

Metabolic Monitoring in Active-Duty Soldiers Prescribed Second-Generation Antipsychotics: A Quality Improvement Project Antipsychotics

Montelukast and Risk for Antidepressant Treatment Failure Antidepressants VA Montelukast Depression Treatment Failure

Olanzapine and Gabapentin Combination Treatment for the Relief of Intractable Hiccups: A Case Report Adherence Antipsychotics Neurology Sleep Disorder Suicide

Olanzapine or Clozapine with Valproic Acid Treatment in patients with Severe Mental Illness (SMI) and the Risk of COVID-19 infection at a State Psychiatric Hospital: a retrospective case control study Antipsychotics Mood Stabilizers COVID-19

Olanzapine-Induced Elevated Liver Function Tests in a Patient Treated for Antidepressant-Induced Mania: A Case Report Antidepressants Antipsychotics

Opioid Overdose Responder Training: Expanding Undergraduate Student Understanding and Awareness of Naloxone Use Education/Stigma Opioids Substance-Use Disorders Naloxone Harm Reduction

Outcomes of Buprenorphine/Naloxone Assisted Treatment in Veterans with Opioid Use Disorder Opioids Substance-Use Disorders VA Opioid Use Disorder

Outcomes of Opioid and Benzodiazepine Co-Prescribing After a Prior Authorization Consult Implementation Opioids VA

Perceptions and Efficacy of Brexanolone for the Treatment of Postpartum Depression: A Mixed Methods Analysis Antidepressants Suicide Postpartum Depression

Perceptions of Adverse Drug Reactions amongst Healthcare Professionals within Inpatient State Psychiatric Facilities Adherence Antidepressants Antipsychotics Anxiolytics Adverse Drug Reaction

Persistency and Outcomes of Pharmacist-led Screening, Brief intervention, and Referral to Treatment for Heavy Drinking in a VA Ambulatory Care Clinic VA Alcohol Use Disorder Ambulatory Care

Pharmacist Attitudes Towards Transgender Patients Education/Stigma Transgender Inclusivity Gender

Pharmacist Initiated Medication Reconciliation Transitions Of Care Medication Reconciliation

Pharmacist Provision of Education and Recommendations for Medications for Alcohol Use Disorder (MAUD) on an Inpatient Medical Unit Substance-Use Disorders Transitions Of Care Alcohol Use Disorder

Pharmacist versus Non-Pharmacist Management on Antidepressant Adherence Rates and Associated Outcomes Among Veterans with Depressive Disorders Adherence Antidepressants VA

Pharmacist-managed Cardiovascular Risk Reduction Outcomes in Individuals Experiencing Serious Mental Illness and Diabetes Compared to Other Provider-managed Primary Care Antipsychotics Metabolic Syndrome Cardiovascular Risk Reduction Serious/severe Psychiatric/mental Disorder/ Illness Diabetes

Pharmacists Knowledge and Attitudes Regarding Cannabidiol Uses, Risks, and Adverse Events Anxiolytics Education/Stigma Substance-Use Disorders

Pharmacists’ Impact on Optimization of Benzodiazepine Use and Polypharmacy at Oregon State Hospital Anxiolytics Opioids

Pharmacists’ Impact on Psychotropic Use in a Veterans Affairs Community Living Center Adherence Antidepressants Antipsychotics Anxiolytics Education/Stigma Geriatrics Neurology Post-Traumatic Stress Disorder/ PTSD Sleep Disorder Transitions Of Care VA Mood Stabilizers Long-Term Care Community Living Center Geropsychiatry Psychotropics Fall Rates

Pharmacists’ Utilization of Prescriptive Authority of Naloxone and Tobacco Cessation Products in Idaho Long-Acting Injectable Prescriptive Authority Naloxone Smoking Cessation

Pharmacogenetic Testing Implementation in a Rural Pediatric Psychiatric Hospital Child And Adolescent Psychiatry Pharmacogenomics

Portrayal of Autism Spectrum Disorders and Related Treatments in Qatar's Printed Media Autism Spectrum Disorder Stigma Media

Prazosin Versus Clonidine for Treatment of Posttraumatic Stress Disorder Associated Nightmares Adherence Post-Traumatic Stress Disorder/ PTSD VA Nightmares Prazosin Clonidine Trauma

Predictors of Persistence and Adherence to Deutetrabenazine Among Patients With Huntington’s Disease Adherence Persistence Neurology VMAT2 Inhibitors Huntington's Disease Chorea

Predictors of Persistence and Adherence to Deutetrabenazine Among Patients With Tardive Dyskinesia Adherence Persistence VMAT2 Inhibitors Tardive Dyskinesia

Prenatal Cannabinoid Exposure Mediated Effects On Cerebellar Oxidative Stress and Mitochondrial Function In Adolescent Rat Offspring Child And Adolescent Psychiatry Neurology Pharmacogenomics Substance-Use Disorders Cannabinoids Synaptic Plasticity Glutamate Learning And Memory Cerebellum

Prescribing Delays in Clozapine and Associated Outcomes Antipsychotics Education/Stigma Clozapine Treatment Resistance

Prospective Pilot Study on the Clinical and Financial Outcomes of Expanding Clinical Pharmacy Services at an Inpatient Behavioral Health Center Adherence Antipsychotics Transitions Of Care Mood Stabilizers

Psychiatric Drug-Nutrient Interactions Of Vitamin D: A Retrospective Study Antidepressants Antipsychotics Anxiolytics Pharmacogenomics Vitamin D Drug-Drug Interactions

Psychiatric Emergency Services Recidivism and Discharge Medications Transitions Of Care Psychiatric Emergency Services Discharge Medications Recidivism

Publication Rates of PGY-2 Psychiatric Pharmacy Residency Projects and Perceived Barriers/Value to Publication Education/Stigma

Quality of Patient Care by Converting to Injectable Antipsychotics with Longer Duration of Actions During COVID-19 Pandemic Adherence Antipsychotics Long-Acting Injectable VA COVID-19

Quantifying Anticholinergic Burden and Assessing Its Relationship With Cognitive Function in Women With and Without Schizophrenia Antipsychotics Anticholinergic Cognition Schizophrenia

Racial Demographics of Patients Who Received More Than One Dose of One-Time As-Needed Injectable Antipsychotics Antipsychotics Short-Acting Injectable

Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Parallel Group Study to Evaluate the Efficacy and Safety of the Amphetamine Extended-Release Tablet (AMPH ER TAB) in Adults with Attention-Deficit/Hyperactivity Disorder Stimulants ADHD Amphetamine

Readmission Rates for Methamphetamine-Positive Patients Receiving Long-Acting Injectable Antipsychotics (LAIAs) Antipsychotics Long-Acting Injectable Substance-Use Disorders

Readmission Rates of Patients Discharged from Adult Psychiatric Facilities Prescribed a Second Generation Long-acting Injectable Antipsychotic Compared to the Oral Formulation Adherence Antipsychotics Long-Acting Injectable Substance-Use Disorders Forensic Community Hospital

Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease Adherence Neurology VMAT2 Inhibitors Huntington's Disease Chorea Treatment Patterns

Relationship between Pharmacy Student Engagement in Curricular and Co-curricular Activities and Wellbeing Education/Stigma Wellness Co-Curricular Activities

Relationship of Frequency of Lithium Administration on Time in Therapeutic Range and Treatment Effectiveness VA Mood Stabilizers Monitoring

Response and Adverse Effects of Intranasal Esketamine on a Patient Cohort in a Hospital Outpatient Clinic: A Descriptive Study. Antidepressants Suicide Mood Stabilizers Esketamine Treatment-Resistant Depression Depression

Role of Impaired Glucose Metabolism in Treatment Outcomes for Patients with Bipolar Disorder Bipolar Disorder Diabetes Healthcare Resource Utilization

Ropinirole-Induced Amnesia and Hallucinations: A Case Report Geriatrics Restless Leg Syndrome

Scoping Review of Policies Regarding Use of Medications for Opioid-use Disorder in Professional Recovery Programs Education/Stigma Opioids Substance-Use Disorders Transitions Of Care Professional Recovery Programs Opioid Use Disorder

Seizure secondary to Fluzone Quadrivalent vaccination in a patient with severe mental illness: A case report Antipsychotics Education/Stigma Vaccinations Febrile Seizures

Societal Burden Associated with Schizophrenia Relapse among US Veterans VA Schizophrenia Veteran Premature Mortality Homelessness Unemployment

Specialty Pharmacist Management and Monitoring of Prescription Cannabidiol Neurology Cannabidiol Seizure Disorders

Stimulant Prescribing Management at a Large Outpatient Facility Stimulants VA ADHD

Stress and Substance Use Among Doctor of Pharmacy Students in a College of Pharmacy Education/Stigma Substance-Use Disorders

Suicide Prevention Training “Boosters” for Student Pharmacists: Evaluation with SAVE Training Education/Stigma Suicide

Survey of Non-Controlled Medication Misuse Patterns Education/Stigma Substance-Use Disorders Medication Misuse

Telepsychiatry for Assessing and Managing Tardive Dyskinesia: Expert Insights from a Cross-Disciplinary Virtual Treatment Panel Antipsychotics Tardive Dyskinesia Valbenazine Telehealth

The COVID-19 Pandemic’s Differential Impact on the Stress Levels of Faculty Versus Administrators of US Pharmacy Schools. Education/Stigma COVID-19 Pharmacy Faculty Stress Anxiety Survey

The Effects of Amantadine on Individuals with Dementia-related Behaviors Geriatrics Neurology Dementia

The Impact of Atypical Antipsychotic Nomenclature on Patients With Bipolar Disorder: Results of a Nationwide Patient Survey Antidepressants Antipsychotics Education/Stigma Mood Stabilizers Nomenclature Atypical Antipsychotic

The Impact of Early Initiation of Clozapine in Veterans With Psychotic Disorders on Hospitalization, Psychiatric Hospitalization, and Mortality Rate Antipsychotics Treatment-Resistant Schizophrenia/ Treatment Refractory Schizoph

The Impact of Pharmacy Students' Understanding of Psychiatry on Personal Growth and Patient Treatment Education/Stigma Mental Illness

The Impact of Pharmacy-Driven Physician Naloxone Training on an Inpatient Psychiatric Unit Education/Stigma Substance-Use Disorders

The Impact of Selective Serotonin Reuptake Inhibitors (SSRIs) on Patient Violence and Aggression: A Retrospective Analysis Antidepressants Education/Stigma Suicide

The Impact of Social Restrictions during COVID-19 on the use of as-needed/one-time (PRN/OT) psychotropic medications in an inpatient state psychiatric hospital Neurology Social Restrictions COVID 19

The Systematic Analysis of Psychiatric Outcomes in Patients Converted from 1-month to 3-month Paliperidone Palmitate Long-Acting Injections Adherence Antipsychotics Long-Acting Injectable

Topiramate-Induced Renal Calculus in a Patient with Schizoaffective Disorder: A Case Report and Review of the Literature for Drug-Induced Renal Calculi Transitions Of Care Renal Calculi Anticonvulsants Schizoaffective Disorder

Toxic Clozapine Level as First Indication of Decreased Clearance During Severe, Acute Illness: An evaluation of concentration-to-dose ratios Antipsychotics Infectious Disease Therapeutic Drug Monitoring

Trends in Absence Time and Payments Due to Long- and Short-Term Disability and Workers' Compensation for Employees with Multiple Sclerosis in the United States Neurology Disability Absence

Trends in the Prescribing Patterns of Long-Acting Injectable Antipsychotics within a Psychiatric Community Health System Antipsychotics Long-Acting Injectable

Understanding the Impact of COVID-19 on Schizophrenia Population Health Management: A Mixed-methods Study of Population Health Decision Makers Adherence Antipsychotics COVID-19 Population Health Management

Use of Prescription Cannabidiol for the Management of Seizure Disorders at an Integrated Care Center Neurology Cannabidiol Seizure Disorders

Use of Vitamin C, Vitamin D, Zinc, and Melatonin as Synergistic Adjuvant Therapy in patients with COVID-19 infection at a psychiatric hospital: a retrospective study COVID-19

Using Item 8 of the Abnormal Involuntary Movement Scale (AIMS) to Assess Improvement in Patients with Tardive Dyskinesia Antipsychotics Tardive Dyskinesia Valbenazine

Utilizing MHFA-trained Student Pharmacists to Conduct Depression Screenings Student Pharmacist Depression Screening Community Pharmacy

Virtual Burnout: The Impact of Virtual Learning During the COVID-19 Pandemic on Perceived Stress Among Minority Pharmacy Students in an Urban Setting Stress COVID-19 Urban-Setting

Vitamin D Monitoring and Supplementation in Psychiatric Inpatients During the COVID-19 Pandemic COVID-19 Vitamin D